Detailansicht

Wissensnetz

Person

Markus W. Löffler (1978-)

Arzt

Name	Markus W. Löffler
Zeit	1978- (Lebensdaten)
Ort	Tübingen (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. med. (Univ. Tübingen) (2009)
Beruf	Arzt (charakteristischer Beruf)
Variante	Markus Willi Löffler Markus Löffler
Beziehung	Klinisches Experiment (M.Sc.) (Studienfach)
Weitere Angaben	Habil. Fachgebiet Experimentelle Medizin, Universität Tübingen, Abt. Immunologie
Datensatztyp	Person
GND-Nummer	13832316X
Datensatz-ID	13832316X
Beteiligt an alle anzeigen A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2 Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency Aktueller Stand der chirurgischen Therapie peritonealer Metastasen bei kolorektalen Karzinomen Integrin activation enables rapid detection of functional Vδ1 + and Vδ2 + γδ T cells A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany : Preparing for further challenges ahead Einfluss der Coronapandemie auf die Leberchirurgie und Lebertransplantationen in Deutschland A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany SARS-CoV-2-Infektionen und klinische Konsequenzen bei organtransplantierten Patienten im Rahmen der ersten Ansteckungswelle in Deutschland-eine monozentrische Umfrage und ein Fallbericht ASO Visual Abstract: A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis Addressing key challenges for unlocking T cell-mediated immunity through peptide vaccination against cancer Designing a SARS-CoV-2 T-cell-inducing vaccine for high-risk patient groups SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick? Individualisierte Immuntherapie von Tumorerkrankungen mittels Peptidimpfstoffen – Funktioniert das vielleicht doch? A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols Laktat verändert die Genexpression humaner Endothelzellen (HUVEC)

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Markus W. Löffler (1978-)

A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2

Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

Aktueller Stand der chirurgischen Therapie peritonealer Metastasen bei kolorektalen Karzinomen

Integrin activation enables rapid detection of functional Vδ1 + and Vδ2 + γδ T cells

A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany : Preparing for further challenges ahead

Einfluss der Coronapandemie auf die Leberchirurgie und Lebertransplantationen in Deutschland

A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany

SARS-CoV-2-Infektionen und klinische Konsequenzen bei organtransplantierten Patienten im Rahmen der ersten Ansteckungswelle in Deutschland-eine monozentrische Umfrage und ein Fallbericht

ASO Visual Abstract: A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma

A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma

ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis

Addressing key challenges for unlocking T cell-mediated immunity through peptide vaccination against cancer

Designing a SARS-CoV-2 T-cell-inducing vaccine for high-risk patient groups

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study

Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick?

Individualisierte Immuntherapie von Tumorerkrankungen mittels Peptidimpfstoffen – Funktioniert das vielleicht doch?

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications

Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation

Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies

Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols

Laktat verändert die Genexpression humaner Endothelzellen (HUVEC)